'Stronger capital markets needed in Biotech Act', says Belgian biotech leader

EURACTIV - Jérôme Van Biervliet, managing director of Belgium's VIB, has called on Brussels to make access to capital the centrepiece of its forthcoming Biotech Act, warning that Europe's fragmented markets risk driving innovation overseas. Read more

Jérôme Van Biervliet [Credit: Science for Health / Kris Van de Sande]